Compare · CBUS vs SNES
CBUS vs SNES
Side-by-side comparison of Cibus Inc. (CBUS) and SenesTech Inc. (SNES): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CBUS and SNES operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- CBUS is the larger of the two at $98.6M, about 26.0x SNES ($3.8M).
- SNES has been more active in the news (5 items in the past 4 weeks vs 1 for CBUS).
- CBUS has more recent analyst coverage (4 ratings vs 0 for SNES).
- Company
- Cibus Inc.
- SenesTech Inc.
- Price
- -
- -
- Market cap
- $98.6M
- $3.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- 2016
- News (4w)
- 1
- 5
- Recent ratings
- 4
- 0
SNES
SenesTech Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Latest CBUS
- Cibus and Crystal Crop Protection Team Up to Improve India’s Mustard Crop
- SEC Form 10-Q filed by Cibus Inc.
- Cibus Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cibus Reports Second Quarter Financial Results and Provides Business Update
- Cibus to Report Second Quarter 2026 Financial Results on August 13, 2026 After the Market Close and Host Conference Call
- SEC Form S-8 filed by Cibus Inc.
- SEC Form S-8 filed by Cibus Inc.
- Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
- CEO Wichner Craig was granted 894,309 shares (SEC Form 4)
- Cibus Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
Latest SNES
- SEC Form 8-K filed by SenesTech Inc.
- SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth
- SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth
- Chief Executive Officer Edell Michael bought $1,289 worth of shares (2,000 units at $0.64), increasing direct ownership by 22% to 11,000 units (SEC Form 4)
- SenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused Consumers
- SenesTech to Participate in the Lytham Partners Fall 2026 Investor Conference
- Chief Executive Officer Edell Michael bought $840 worth of shares (1,000 units at $0.84), increasing direct ownership by 12% to 9,000 units (SEC Form 4)
- Chief Executive Officer Edell Michael bought $1,740 worth of shares (2,000 units at $0.87), increasing direct ownership by 33% to 8,000 units (SEC Form 4)
- Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® Rat
- SenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)